Dexamethasone / Tobramycin
Dexamethasone / tobramycin is a prescription eye antibiotic-steroid combination used to treat inflammatory eye conditions while protecting against bacterial infection.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 28 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Dexamethasone / Tobramycin: Patient Information Guide
A plain-language walkthrough of Dexamethasone / Tobramycin — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Dexamethasone / tobramycin is a prescription combination used in the eye when both an anti-inflammatory steroid and antibiotic coverage are needed together. Supported uses across the available products include:
- Inflammatory conditions of the conjunctiva (the clear membrane covering the white of the eye) and cornea where a steroid is appropriate
- Inflammation of the anterior segment (front portion) of the eye
- Chronic anterior uveitis (ongoing inflammation inside the eye)
- Eye injury from chemical, radiation, or thermal burns, or penetration by a foreign body
- Situations where the risk of superficial bacterial eye infection is high, or where dangerous numbers of bacteria are likely present
Tobradex ST eye drops, Tobramycin and Dexamethasone eye drops, and TobraDex ointment all share these general indications. Product-specific details on dosing and formulation differ — see the form guidance section.
⚙️How it works▾
This combination works through two separate mechanisms. Dexamethasone is a potent corticosteroid — it suppresses the inflammatory response in the eye by reducing the activity of immune and inflammatory cells, which eases swelling, redness, and pain. Tobramycin is an aminoglycoside antibiotic that stops bacteria from making the proteins they need to survive, effectively halting their growth. Because the steroid alone can lower the eye's natural defenses and increase the risk of infection, tobramycin is included to help guard against susceptible bacteria.
In laboratory studies, tobramycin has also shown activity against some bacteria that are resistant to gentamicin, a related antibiotic — meaning it can cover a wider range of organisms in certain cases.
💊How it's taken▾
These products are applied directly to the eye — never swallowed or injected. Dosing frequency varies by product and by the severity of your condition at the start of treatment, so always follow your prescriber's exact instructions.
- Tobradex ST eye drops: typically one drop in the affected eye every 4 to 6 hours; may be increased to every 2 hours during the first 24–48 hours, then tapered as the eye improves. Shake well before use.
- Tobramycin and Dexamethasone eye drops: typically one or two drops every 4 to 6 hours; may be increased to every 2 hours in the first 24–48 hours.
- TobraDex ointment: a small ribbon (about half an inch) applied inside the lower eyelid up to three or four times daily.
Do not stop treatment early without talking to your doctor — incomplete treatment may allow inflammation or infection to return. Your doctor will re-evaluate you before authorizing a refill.
🤒Side effects — in detail▾
Side effects can come from either the antibiotic or the steroid component. The most common ones reported include:
- Eye pain
- Itching of the eyelids
- Eyelid swelling
- Eye redness (conjunctival hyperemia)
- Temporary blurred vision right after applying the medication
- Increased pressure inside the eye (intraocular pressure)
- Headache
- Increased blood pressure
More serious reactions to watch for include signs of rising eye pressure leading to glaucoma, cataract formation with prolonged use, a new or worsening eye infection, and allergic reactions ranging from local skin redness and itching to rare but serious whole-body reactions such as anaphylaxis. Contact your doctor or seek emergency help if you experience any of these.
⚠️Warnings & precautions▾
- Increased eye pressure and glaucoma: Prolonged corticosteroid use can raise intraocular pressure, potentially damaging the optic nerve and causing vision loss. If you use this for 10 days or more, your doctor should check your eye pressure regularly.
- Cataract formation: Long-term steroid use in the eye can lead to a specific type of cataract (posterior subcapsular cataract) forming at the back of the eye's lens.
- Delayed healing and corneal risk: Steroids can slow healing after cataract surgery and, in people with conditions that thin the cornea or sclera, can even cause perforation (a hole forming in the eye wall).
- Masking or worsening infection: Steroids suppress immune defenses, which can hide a bacterial infection or allow it to worsen. If your eye is not improving after 2 days, see your doctor promptly.
- Viral and fungal infections: This medication must not be used for herpes-related or other viral eye infections, and fungal eye infections can develop or worsen with steroid use — especially with long-term use.
- Allergic reactions: Sensitivity to the aminoglycoside antibiotic (tobramycin) can range from local eye irritation to serious whole-body reactions. Stop use and seek care if this occurs.
- Contact lens use (Tobradex ST): Tobradex ST contains a preservative that soft contact lenses can absorb — do not wear soft lenses during treatment.
🔀What it interacts with▾
There are two key interaction concerns to be aware of with this medication:
- CYP3A4 inhibitors (examples include certain antifungal medications, some HIV drugs, and other medicines that block this liver enzyme) — these can increase the amount of dexamethasone that enters the bloodstream and may raise the risk of systemic steroid effects such as Cushing's syndrome (a condition from too much steroid exposure) or suppression of the adrenal glands, especially in children and those predisposed to these effects. Tell your doctor about all medications you take.
- Soft contact lenses — Tobradex ST eye drops contain benzalkonium chloride, a preservative that can be absorbed into soft contact lens material. Remove soft lenses before applying and ask your doctor or pharmacist when it is safe to reinsert them.
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not use if you have a viral eye infection — including herpes simplex keratitis (dendritic keratitis), chickenpox (varicella), or vaccinia involving the eye
- Do not use if you have a fungal or mycobacterial (such as tuberculosis-related) infection of the eye
- Tell your doctor if you have ever had herpes simplex eye disease — using a steroid in that setting requires great caution and close monitoring
- Tell your doctor about any allergy to tobramycin, dexamethasone, other aminoglycoside antibiotics, or any ingredient in these products
- Tell your doctor if you are pregnant or planning to become pregnant — corticosteroids have caused fetal harm in animal studies, and prolonged use during human pregnancy may be associated with reduced fetal growth; use only if clearly necessary
- Tell your doctor if you are breastfeeding — it is not fully known whether topical ophthalmic corticosteroids reach breast milk, so caution is advised
- Safety and effectiveness in children under 2 years old have not been established
- Tell your doctor if you have any condition that causes thinning of the cornea or sclera — the steroid component can increase the risk of a perforation
- Tell your doctor if you have or suspect neuromuscular disorders such as myasthenia gravis or Parkinson's disease — aminoglycosides may worsen muscle weakness
🚑If you take too much▾
If too much of this medication is applied to the eye, signs can include punctate keratitis (small erosions on the cornea's surface), redness, increased tearing, eye swelling, and itchy eyelids — similar to some of the known side effects. Contact your doctor or poison control center if you are concerned about accidental overuse.
🔬Pharmacokinetics — how your body processes it▾
When applied to the eye, dexamethasone reaches the aqueous humor (the fluid inside the front of the eye) relatively quickly. After a single dose of Tobradex ST, concentrations in the aqueous humor peaked at an average of 33.7 ng/mL at about 2 hours. With regular use of tobramycin and dexamethasone ophthalmic suspension (four times a day for 2 days), peak levels of dexamethasone in the bloodstream were very low — less than 1 ng/mL — occurring within 2 hours after each dose, meaning systemic exposure is minimal. The extent to which tobramycin is absorbed into the bloodstream from Tobradex ST eye drops is not fully known.
📦How to store it▾
Store upright at 20°-25°C (68°-77°F).
📄 Written from Dexamethasone / Tobramycin’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Dexamethasone / Tobramycin — the kind of thing our pharmacy team would talk through with you at the counter.
What exactly is this eye drop treating — is it for an infection or inflammation? ▾
How do I put in the eye drops or ointment correctly? ▾
Can I wear my contact lenses while using this? ▾
How long will I need to use this, and is it safe to stop early? ▾
Are there any serious risks I should know about if I use this for a long time? ▾
Is it safe to use if I'm pregnant or breastfeeding? ▾
Is Dexamethasone / Tobramycin available over the counter? ▾
When was Dexamethasone / Tobramycin first available? ▾
Who makes Dexamethasone / Tobramycin? ▾
💬 Answers drafted from Dexamethasone / Tobramycin’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Dexamethasone / Tobramycin comes
Dexamethasone / Tobramycin is available in 2 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Eye drops
How this form is used
- Tobradex ST is used for steroid-responsive inflammatory eye conditions where bacterial infection or risk of infection is present
- Tobramycin and Dexamethasone eye drops are used for the same steroid-responsive inflammatory ocular conditions with bacterial infection risk
- Both eye drop products are used for conditions including anterior uveitis and eye injury from burns or foreign bodies
- Tobradex ST: instill one drop into the lower eyelid pocket every 4 to 6 hours; during the first 24–48 hours your doctor may increase this to every 2 hours
- Tobramycin and Dexamethasone drops: instill one or two drops every 4 to 6 hours; during the first 24–48 hours dosing may increase to every 2 hours
- Tobradex ST: shake the bottle well before each use
- Tobradex ST: do not wear soft contact lenses during treatment — the preservative benzalkonium chloride can be absorbed by soft lenses
Eye ointment
How this form is used
- TobraDex ointment is used for steroid-responsive inflammatory eye conditions where bacterial infection or risk of infection is present
- TobraDex ointment is used for conditions including anterior uveitis and eye injury from chemical, radiation, or thermal burns, or foreign bodies
- TobraDex ointment: apply approximately a half-inch ribbon inside the lower eyelid pocket up to three or four times daily
- TobraDex ointment: tilt your head back, gently pull down your lower eyelid to form a pocket, apply the ointment, and look downward before closing your eye
- TobraDex ointment: do not let the tip of the tube touch your eye or any surface
📊 Dexamethasone / Tobramycin across the U.S. market
How Dexamethasone / Tobramycin appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Dexamethasone / Tobramycin is used
A general measure of how commonly Dexamethasone / Tobramycin is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Dexamethasone / Tobramycin is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Dexamethasone / Tobramycin prescribed? Of the 1,596 medications we measure, Dexamethasone / Tobramycin ranks #456 by Medicaid prescriptions — more than 71% of them.
Utilization by Dexamethasone / Tobramycin product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
dexamethasone 1 MG/ML / tobramycin 3 MG/ML Ophthalmic Suspension Most dispensed
Summed across the 9 of 45 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 309683
dexamethasone 0.001 MG/MG / tobramycin 0.003 MG/MG Ophthalmic Ointment
Summed across the 1 of 3 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 309682
dexamethasone 0.5 MG/ML / tobramycin 3 MG/ML Ophthalmic Suspension
Summed across the 2 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 849115
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Dexamethasone / Tobramycin, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 12 of 53 listed Dexamethasone / Tobramycin NDCs with Medicaid activity.
🔍 Compare Dexamethasone / Tobramycin products
A representative set of FDA-listed product records for Dexamethasone / Tobramycin — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Eye drops | ||||
| TOBRAMYCIN 3 mg/mL; DEXAMETHASONE 1 mg/mL | Ophthalmic | A-S Medication Solutions × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| TOBRAMYCIN 3 mg/mL; DEXAMETHASONE 1 mg/mL | Ophthalmic | A-S Medication Solutions × 2 listings | ANDA | View NDC → |
| 1; 3 mg/mL; mg/mL | Ophthalmic | A-S Medication Solutions | NDA AUTHORIZED GENERIC | View NDC → |
| 1; 3 mg/mL; mg/mL | Ophthalmic | A-S Medication Solutions × 3 listings | ANDA | View NDC → |
| TOBRAMYCIN 3 mg/mL; DEXAMETHASONE 1 mg/mL | Ophthalmic | Advanced Rx of Tennessee, LLC | NDA AUTHORIZED GENERIC | View NDC → |
| TOBRAMYCIN 3 mg/mL; DEXAMETHASONE 1 mg/mL | Ophthalmic | Advanced Rx Pharmacy of Tennessee, LLC | ANDA | View NDC → |
| 1; 3 mg/mL; mg/mL | Ophthalmic | Advanced Rx Pharmacy of Tennessee, LLC | NDA AUTHORIZED GENERIC | View NDC → |
| 1; 3 mg/mL; mg/mL | Ophthalmic | Advanced Rx Pharmacy of Tennessee, LLC | ANDA | View NDC → |
| 1; 3 mg/mL; mg/mL | Ophthalmic | Alcon Laboratories, Inc. | NDA | View NDC → |
| 1; 3 mg/mL; mg/mL | Ophthalmic | Amneal Pharmaceuticals NY LLC × 6 listings | ANDA | View NDC → |
| TOBRAMYCIN 3 mg/mL; DEXAMETHASONE 1 mg/mL | Ophthalmic | Bausch & Lomb Incorporated | ANDA | View NDC → |
| 1; 3 mg/mL; mg/mL | Ophthalmic | Bausch & Lomb Incorporated | ANDA | View NDC → |
| TOBRAMYCIN 3 mg/mL; DEXAMETHASONE 1 mg/mL | Ophthalmic | Bryant Ranch Prepack × 7 listings | ANDA | View NDC → |
| 1; 3 mg/mL; mg/mL | Ophthalmic | Bryant Ranch Prepack × 3 listings | ANDA | View NDC → |
| TOBRAMYCIN 3 mg/mL; DEXAMETHASONE 0.5 mg/mL | Ophthalmic | Eyevance Pharmaceuticals, LLC | NDA | View NDC → |
| 0.5; 3 mg/mL; mg/mL | Ophthalmic | Eyevance Pharmaceuticals, LLC × 2 listings | NDA | View NDC → |
| TOBRAMYCIN 3 mg/mL; DEXAMETHASONE 0.5 mg/mL | Ophthalmic | Harrow Eye, LLC | NDA | View NDC → |
| 1; 3 mg/mL; mg/mL | Ophthalmic | Novartis Pharmaceuticals Corporation × 2 listings | NDA | View NDC → |
| TOBRAMYCIN 3 mg/mL; DEXAMETHASONE 1 mg/mL | Ophthalmic | NuCare Pharmaceuticals,Inc. × 3 listings | ANDA | View NDC → |
| 1; 3 mg/mL; mg/mL | Ophthalmic | NuCare Pharmaceuticals,Inc. × 3 listings | ANDA | View NDC → |
| 1; 3 mg/mL; mg/mL | Ophthalmic | NuCare Pharmaceuticasl,Inc. | ANDA | View NDC → |
| DEXAMETHASONE 1 mg/mL; TOBRAMYCIN 3 mg/mL | Ophthalmic | Padagis US LLC | ANDA | View NDC → |
| TOBRAMYCIN 3 mg/mL; DEXAMETHASONE 1 mg/mL | Ophthalmic | Padagis US LLC | ANDA | View NDC → |
| 1; 3 mg/mL; mg/mL | Ophthalmic | Padagis US LLC | ANDA | View NDC → |
| TOBRAMYCIN 3 mg/mL; DEXAMETHASONE 1 mg/mL | Ophthalmic | Preferred Pharmaceuticals Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 1; 3 mg/mL; mg/mL | Ophthalmic | Quality Care Products, LLC | ANDA | View NDC → |
| TOBRAMYCIN 3 mg/mL; DEXAMETHASONE 1 mg/mL | Ophthalmic | Redpharm Drug | ANDA | View NDC → |
| TOBRAMYCIN 3 mg/mL; DEXAMETHASONE 1 mg/mL | Ophthalmic | Remedyrepack Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| TOBRAMYCIN 3 mg/mL; DEXAMETHASONE 1 mg/mL | Ophthalmic | Sandoz Inc | NDA AUTHORIZED GENERIC | View NDC → |
| 1; 3 mg/mL; mg/mL | Ophthalmic | Sandoz Inc | NDA AUTHORIZED GENERIC | View NDC → |
| TOBRAMYCIN 3 mg/mL; DEXAMETHASONE 1 mg/mL | Ophthalmic | Sportpharm LLC × 2 listings | ANDA | View NDC → |
| 💊Eye ointment | ||||
| DEXAMETHASONE 1 mg/g; TOBRAMYCIN 3 mg/g | Ophthalmic | Novartis Pharmaceuticals Corporation | NDA | View NDC → |
| TOBRAMYCIN 3 mg/g; DEXAMETHASONE 1 mg/g | Ophthalmic | Novartis Pharmaceuticals Corporation | NDA | View NDC → |
| 1; 3 mg/g; mg/g | Ophthalmic | Novartis Pharmaceuticals Corporation × 2 listings | NDA | View NDC → |
Showing 59 of 59 products — FDA National Drug Code Directory. See every product, package size and price: browse all 59 Dexamethasone / Tobramycin NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Dexamethasone / Tobramycin — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Dexamethasone / Tobramycin in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Dexamethasone / Tobramycin went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one exact multiple-ingredient concept (MIN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). A product with a different ingredient combination belongs on a different page.
RxCUI 883815 2 dose forms · 3 strengths
-
Dose form (SCDF) Ophthalmic Ointment RxCUI 374438In current FDA listingsClinical drug / strength (SCD) dexamethasone 0.001 MG/MG / tobramycin 0.003 MG/MGRxCUI 309682 -
Dose form (SCDF) Ophthalmic Suspension RxCUI 378984In current FDA listingsClinical drug / strength (SCD) dexamethasone 0.5 MG/ML / tobramycin 3 MG/MLRxCUI 849115dexamethasone 1 MG/ML / tobramycin 3 MG/MLRxCUI 309683
Look up RxCUI 883815 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Dexamethasone / Tobramycin is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
RxNorm drug class
Dexamethasone / Tobramycin belongs to the Aminoglycoside Antibacterial class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 28 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Harrow Eye, LLC is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.